Marjorie Zauderer

13PUBLICATIONS
130CO-AUTHORS
Commercial lawMolecular targetsHaematological tumoursCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 01, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

|Dec 18, 2024
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U.

Marjorie G Zauderer, Opeyemi Jegede, David M Jackman

|Nov 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

|Apr 17, 2024
Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features.

Soo-Ryum Yang, Gowtham Jayakumaran, Jamal Benhamida

|Feb 21, 2024
The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.

Hiroki Sato, Tatsuo Ito, Takuo Hayashi

|Feb 04, 2023
Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations.

Allison Lipitz-Snyderman, Susan Chimonas, Sham Mailankody

Pageof 3

Frequent Collaborators

3 joint publications

David R Jones

3 joint publications

Charles M Rudin

3 joint publications

Róisín Eilish O'Cearbhaill

2 joint publications

Gilberto Lopes